Microneedle SkinJect patch aims to clear basal cell carcinoma without surgery, showing phase 2 promise and expanding to Gorlin syndrome trials.
Raza Bokhari, MD
Advertisement
Raza Bokhari, MD, is the executive chairman and chief executive officer of Medicus Pharma.
Articles by Raza Bokhari, MD
Dissolvable microneedles deliver doxorubicin to basal cell lesions, showing promising phase 2 clearance and opening hope for Gorlin syndrome patients.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinique's Daily Calm Merges Clinical Efficacy with Color Cosmetics for Sensitive Skin
2
Clear Health Launches Topical Isotretinoin Acne Treatment Without iPLEDGE Requirements
3
First HA Injectable for Neck Wrinkles Cleared by FDA
4
A Look Back at RAD 2025 Before This Year’s Encore in Music City
5